Compare Exelon Corporation Common Stock (EXC) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelon Corporation Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Exelon Corporation Common Stock trades at $41.8 (market cap $42.99B), while Nuvation Bio Inc. Class A Common Stock trades at $5.04 (market cap $1.74B). The key difference: Exelon Corporation Common Stock is far larger — about 24.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| EXC | NUVB | |
|---|---|---|
Market Cap | $42.99B | $1.74B |
Volume | 7,570,408 | 9,289,619 |
Sector | Utilities | Health |
52-Week High | $50.29 | $9.54 |
52-Week Low | $40.20 | $3.41 |
Enterprise Value | $93.85B | $1.33B |
Dividend Yield | 4.03% | — |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
